Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis

• Asıl Yazarlar: Haruna Yamamoto (Yazar), Hiroaki Ikesue (Yazar), Mai Ikemura (Yazar), Rieko Miura (Yazar), Kazumi Fujita (Yazar), Hobyung Chung (Yazar), Yoshiki Suginoshita (Yazar), Tetsuro Inokuma (Yazar), Tohru Hashida (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2018-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Direct-acting antivirals (DAAs) are known to improve tolerability and have higher efficacy and shorter treatment durations compared with conventional interferon (IFN)-based treatments for hepatitis C virus (HCV) infection. Management of drug interactions and maintenance of patien...